NCT02129569
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Case Comprehensive Cancer Center Cleveland, Ohio, United States
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
2,604 public trials
547 recruiting studies
Neoplasms, Plasma Cell trial results
NCT01626547
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chemotherapy-induced Symptomatic Anaemia, +17 more
- Locations
-
- Alzey, Germany
- Bad Säckigen, Germany
- Berlin, Germany
- Berlin, Germany
NCT00259740
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
Not specified
NCT00577642
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT01277016
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Amyloidosis Research and Treatment Center Pavia, Italy
NCT00600353
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
- Locations
-
- University of Kansas Medical Center Kansas City, Kansas, United States
NCT00143845
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +25 more
- Locations
-
- The University of Michigan Ann Arbor, Michigan, United States
NCT00408681
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +221 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00307086
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
Completed
Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases
NCT00434447
- Conditions
- Blood Protein Disorders, Bone Diseases, Bone Neoplasms, +33 more
- Locations
-
- Novartis Investigative Site Canberra, Australian Capital Territory, Australia
- Novartis Investigative Site Concord, New South Wales, Australia
- Novartis Investigative Site Liverpool, New South Wales, Australia
- Novartis Investigative Site Wagga Wagga, New South Wales, Australia